Journal of Cardiovascular Electrophysiology

Article	Citations
Long conduction time from the anterior left atrium to coronary sinus during entrainment pacing of a bi‐atrial tachycardia: What is the mechanism?	136
Issue Information	73
Bringing big data to vascular complications during atrial fibrillation ablation	71
The high‐density grid catheter: A safe adjunctive tool in pediatric and complex congenital heart disease patients	56
Pacemaker‐mediated reentrant arrhythmia facilitated by an atrial‐tracking leadless pacemaker	53
Focal and rotational drivers in persistent atrial fibrillation: Are we chasing ghosts?	53
Radiofrequency ablation of persistent atrial fibrillation in a patient with situs inversus totalis and interrupted inferior vena cava	52
An irregular tachycardia: What is the mechanism?	51
Letter to the Editor regarding: Impact of artificial intelligence arrhythmia mapping on time to first ablation, procedure duration, and fluoroscopy use	43
Comments on “High Power Short Duration Temperature‐Controlled Radiofrequency Ablation for the Treatment of Outflow Tract Ventricular Arrhythmias”	39
	38
Ultrasound‐guided vascular access for CIED implantation: A step‐by‐step guide	38
Accessory Pathway Antegrade Electrophysiologic Features Among Wolff–Parkinson–White Patients: The Risk in Relation to the Location	38
Reconsider the Indication of Implantable Cardioverter Defibrillator in Patients With Cardiac Amyloidosis	35
Multielectrode Radiofrequency Balloon Catheter for Paroxysmal Atrial Fibrillation: Results From the Global, Multicenter, STELLAR Study	34
Elevated fibrosis burden as assessed by MRI predicts cryoballoon ablation failure	33
Narrow complex tachycardia with alternating atrial activation: What is the mechanism?	33
Regarding the article “automatic identification of ablation targets in persistent atrial fibrillation: Initial experience with a new mapping tool”	31
Central venus cannulation during cardiac surgery as a possible new additional risk factor for late post‐operative atrial fibrillation insurgence	31
Comparison of Integrated 3D Electroanatomic Mapping and Conventional Mapping Systems for Pentaspline Pulsed Field Ablation of Atrial Fibrillation	30
A Case of Ventricular Premature Contractions With Multiple Morphologies Reproduced by a Single Ventricular Extrastimulus With Different Coupling Intervals	30
Clinical relevance of the blanking period on late recurrence after catheter ablation of atrial fibrillation	29
Targeted ablation of residual pulmonary vein potentials in atrial fibrillation ablation through ultra‐high‐density mapping: Insights from the CHARISMA registry	29
Ablation of atrial fibrillation beyond pulmonary vein isolation: Do additional ablation lesions impact left atrial function?	28
Evaluation of microembolic signals on carotid ultrasound during pulmonary vein isolation with high‐power short‐duration and cryoballoon ablations: When and where do bubble and solid emboli arise?	28

Sotalol in neonates for arrhythmias: Dosing, safety, and efficacy	28
The Single‐Delayed‐Phase Contrast Computed Tomography Before Ablation to Reduce Radiation Exposure Without Compromising Diagnostic Pulmonary Vein Accuracy	27
Electrical storm after left ventricular assist device (LVAD) implantation	27
“Pill‐in‐Pocket” anticoagulation for stroke prevention in atrial fibrillation	26
A 15‐year follow‐up study of radiofrequency catheter ablation for atrial fibrillation in patients with tachycardia‐bradycardia syndrome	26
Very High‐Power Short‐Duration Ablation for Premature Ventricular Complexes From Sites With Suboptimal Catheter Stability	26
Pulmonary vein reconnection and repeat ablation characteristics following cryoballoon‐ compared to radiofrequency‐based pulmonary vein isolation	26
Incidence and Predictors of Pacing‐Induced Cardiomyopathy in Paced Patients Undergoing Attempted Left Bundle Branch Area Pacing	26
When Propensity Score Does Not Always Match? Letter to the Editor Regarding “Pulsed Field Ablation for Persistent Atrial Fibrillation in EU‐PORIA Registry”	26
Prognostic Value of Small Coved‐Type ST‐Segment Area in Patients With Spontaneous Type 1 Brugada Syndrome	25
Intranodal Atrioventricular Nodal Reentrant Tachycardia Mimicking Junctional Tachycardia	25
Medical cardioversion of atrial fibrillation and flutter with class IC antiarrhythmic drugs in young patients with and without congenital heart disease	25
Age, Frailty, and Outcomes After Atrial Fibrillation Ablation: A Nationwide Cohort Study	24
Long‐Term Impact of GLP‐1 Receptor Agonists on AF Recurrence After Ablation in Obese Patients	24
Step‐by‐step recommendations utilizing four‐dimensional intracardiac echocardiography in left atrial appendage procedures	23
Novel streamlined technique for left atrial appendage closure using a radiofrequency wire‐based large access system	22
Short or long‐coupled idiopathic ventricular fibrillation: Does the coupling interval really matter?	22
First clinical data on artificial intelligence‐guided catheter ablation in long‐standing persistent atrial fibrillation	21
Issue Information	21
Corrigendum	21
	21
Predicting ventricular arrhythmia inducibility in ajmaline‐induced Brugada type I pattern: Validation of the dST‐Tiso interval	20
Temporary Restoration of Sinus Rhythm Improves Outcomes of Catheter Ablation for Longstanding Persistent Atrial Fibrillation	20
Electrogram‐based AF ablation: finally, reproducibility!	20
Cardiopulmonary Exercise Testing‐Guided Beta‐Blocker Dosing in Long QT Syndrome: Genotype, Methodology, and Adherence Concerns	20
Issue Information	19
Feasibility of a novel atrial mechanical sensing method for leadless atrioventricular synchronous pacing	19
Impact of remote reprogramming on insertable cardiac monitors alert burden	19
Factors Affecting the Impact of LBBBP on Ventricular Electrical Activation	19
Ventricular arrhythmias in patients with bicuspid aortic valves	19
	18
Reply to: “Seize the day….s(e)ize the device: The emerging imaging modality to improve left atrial appendage device sizing”	18
Intravascular Lithotripsy to Facilitate Extraction of Very Old Cardiac Implantable Electronic Devices Leads	18
In which patients with heart failure should ablation of atrial fibrillation not be performed?	18
Authors' response to letter to the editor regarding relationship between sodium‐glucose cotransporter two inhibitors and atrial fibrillation recurrence after pulmonary vein isolation in patients with	18
Temporal and spatial pacemap parameters for identification of cardiac surfaces with critical sites for ventricular tachycardia	18
	18
Impedance‐decline‐guide power control long application time bipolar radiofrequency catheter ablation	17
Nonlinear Relationship Between Left Atrial Volume Measured by Computed Tomography and Recurrent Atrial Arrhythmias in Patients Undergoing Catheter Ablation for Atrial Fibrillation	17
The Association Between Newly Acquired Permanent Left Bundle Branch Block Following Transcatheter Aortic Valve Replacement and New‐Onset Cardiomyopathy	17
Visualization of Electrophysiologically Defined Superior Vena Cava‐Right Atrium Junction With High‐Resolution Mapping Using Atrial Extrastimulus	16
Ventricular Tachycardia Ablation in Patients With Severely Decreased Left Ventricular Ejection Fraction	16
COVID‐19 vaccination and atrial fibrillation: When pandemics collide	16
Irreversible electroporation for cardiac ablation: Optimizing cell type‐specific effects	15
Establishing electroporation thresholds for targeted cell specific cardiac ablation in a 2D culture model	15
Lesion monitoring parameters as predictors of atrial arrhythmia recurrence after catheter ablation in persistent AF: A DECAAF II sub‐analysis	15
Leadless Versus Single Chamber Pacemakers: An Analysis From the National Readmissions Database of Adverse Outcomes	15
Acute procedural efficacy and safety of a novel cryoballoon for the treatment of paroxysmal atrial fibrillation: Results from the POLAR ICE study	15
Initial Pre‐Clinical Evaluation of the Augmented Ultra‐Low Temperature Cryoablation Catheter for Ventricular Ablations	15
Costs, efficiency, and patient‐reported outcomes associated with suture‐mediated percutaneous closure for atrial fibrillation ablation: Secondary analysis of a randomized clinical trial	15

Treating syncope without drugs: Standing still, exercising hard, or simply the “expert's touch”?	15
Colchicine usage for prevention of post atrial fibrillation ablation pericarditis in patients undergoing high‐power short‐duration ablation	14
Impact of Pirfenidone on Arrhythmic and Clinical Outcomes in Patients With Idiopathic Pulmonary Fibrosis	14
Convergent ablation for persistent atrial fibrillation: A UK multicentre perspective	14
Introduction of the Low Voltage Bridge Mapping for the AVNRT RF Ablation in Children – Early Follow‐Up Results	14
Impact of Sodium‐Glucose Cotransporter 2 Inhibitor on Recurrence After Catheter Ablation for Atrial Fibrillation in Patients With or Without Metabolic Syndrome	14
Clinical Predictors of Recurrent Cavotricuspid Isthmus Flutter After Catheter Ablation in Patients With Dextro‐Transposition of the Great Arteries	14
Left Atrial Function and Strain Assessed by Three‐Dimensional Echocardiography as Factors Associated With Atrial Fibrillation Recurrence After Pulmonary Vein Ablation	14
Beyond Catheter Design: The Overlooked Role of Fluids in Pulsed Field Ablation Hemolysis	14
Intermittent Ventricular Pre‐Excitation: Clinical Features and Electrophysiological Properties	14
Impact of omitting the intravenous heparin bolus on outcomes of leadless pacemaker implantation	14
Prevalence and Recovery of Arrhythmia‐Induced Cardiomyopathy in Patients With Newly Diagnosed Heart Failure Using a Wearable Defibrillator: A Real‐World Cohort Study	13
“Function follows form”: Role of cardiac magnetic resonance for ventricular arrhythmia risk stratification in patients with cardiac sarcoidosis	13
Removal of an active fixation coronary sinus pacing lead 5 years postimplant: A case report	13
Impact of left atrial low‐voltage areas during initial ablation procedures on very late recurrence of atrial fibrillation	13
Managing ventricular arrhythmias and implantable cardiac defibrillator shocks after left ventricular assist device implantation	13
Two‐To‐One Conduction Between the Inside and Outside of the Left Atrial Posterior Wall During Atrial Tachycardia: What Is the Mechanism?	13
Correction to “Comparison of treatment outcomes between convergent procedure and catheter ablation for paroxysmal atrial fibrillation evaluated with implantable loop recorder monitoring”	13
A device‐related fistula between coronary artery and left atrial appendage following left atrial appendage closure: Case presentation	13
Ethanol Infusion Therapy for Incessant Atrial Tachycardia Arising From the Distal Left Atrial Appendage	13
Practical and systematic approach using the steerable catheter and stylet‐driven lead to deliver safe and effective left bundle branch area pacing	13
A Simplified Epicardial Ablation Strategy for Ventricular Tachycardia Integrating CT‐Derived Epicardial Adipose Tissue Into Three‐Dimensional Electroanatomic Mapping	13
Same‐day discharge following catheter ablation and venous closure with VASCADE MVP: A postmarket registry	13
Comparison of Two Different Pulsed Field Ablation Systems: The Dual Pulse System Study	13
Detailed mechanism of difficulty in cryoablation for atrial fibrillation in patients with very severe obesity	12
Safety of Ablation Within the Coronary Venous Sinus in Pediatric Patients	12
Issue Information	12
Sensing of concealed ventricular extrasystoles by pacemakers. Fifty years later	12
Rationale and Design of the InsightPFA Trial: A Prospective, Multicenter, Randomized Controlled Trial of the Irreversible Electroporation‐Based Pulsed Field Ablation Versus Radiofrequency Ablation in	12
Editorial to: Efficacy and safety of a novel temperature‐controlled catheter for cavotricuspid isthmus ablation	12
Is esophageal temperature management needed during cryoballoon ablation for atrial fibrillation?	12
Outcomes of Exclusive 50 W High Power, 5 s Ablation Close to the Esophagus in Pulmonary Vein Isolation	12
Patient reported QOL and EV‐ICD: Response to letter from Kataoka and Imamura (2024)	12
Nonclinical evaluation of chronic cardiac contractility modulation on 3D human engineered cardiac tissues	12
Quality of life and acceptance of the extravascular implantable cardioverter‐defibrillator	12
Activation signatures for identifying critical isthmi of ventricular tachyarrhythmias	12
Ventricular arrhythmias in patients with prior aortic valve intervention: Characteristics, ablation and outcomes	12
Electrocardiographic Characteristics of Ventricular Arrhythmias Originating From High Right Ventricular Outflow Tract and Pulmonary Artery	11
Dilated, hypertrophic or fibrotic: On the road to a noninvasive atrial substrate classification of atrial fibrillation	11
Issue Information	11
Cost‐Utility Analysis of Left Bundle Branch Area Versus Biventricular Pacing for Cardiac Resynchronization Therapy: A Multicenter, Prospective, Quasi‐Experimental Study	11
	11
Removal of EVICD Leads Are Specialized Tools Required?	11
Combined approach of high‐power and very high‐power, short‐duration ablation in superior vena cava isolation	11
Ventricular tachycardia ablation with pentaspline pulsed field technology in two patients with ischemic cardiomyopathy	11
High‐Power Short‐Duration Ablation Versus Conventional Power Ablation in Pulmonary Vein Isolation in Patients With Atrial Fibrillation: An Updated Systematic Review and Meta‐Analysis of Randomized Con	11
Double atrial potentials in the coronary sinus: What is the mechanism?	11
Correction to “Physiological Pacing: Historical Review With an Eye to the Future”	11
Noninvasive ECG imaging of the intrinsic atrial pacemaker and atrial activation in surgically repaired or palliated congenital heart disease	11
Comparison of HEMOlysis Markers Among Three Pulsed Field Ablation Systems: HEMO‐PFA Study	11
Safety and Efficacy of LockeT Suture Retention Device for Large‐Bore Venous Access Closure	10
Left atrial appendage dimension predicts elevated brain natriuretic peptide in nonvalvular atrial fibrillation. Authors response	10
Widening the scope of complex cardiac implantable electronic devices implant considerations: Time for an integrated multidisciplinary approach	10
	10
Incidence, Predictors, and Outcomes With Ventricular Arrhythmias in Continuous Flow Left Ventricular Assist Device Recipients: A Multicenter Analysis	10
Cover Image, Volume 36, Issue 8	10
Ultrasound guidance for femoral venous access in patients undergoing pulmonary vein isolation: A quasi‐randomized study	10
Idiopathic Premature Ventricular Complexes Originating From Right Ventricular False Tendons	10
“Piece by Piece” understanding of patient reported QOL and EV‐ICD: Response to letter from Vicentini and Rodorf	10
Urgent desensitization for severe amiodarone intolerance with a 12‐step protocol	10
Inflammatory reaction to TYRX antibacterial envelope mimicking infection	10
Cover Image, Volume 35, Issue 12	10
Differential gap location after radiofrequency versus cryoballoon pulmonary vein isolation: Insights from a randomized trial with protocol‐mandated repeat procedure	10
Letter to the Editor: Sodium‐Glucose Cotransporter‐2 Inhibitors and Stroke Risk in Patients With Atrial Fibrillation	10
Lesion Depth Optimization in High‐Power Radiofrequency Ablation: Evaluating Single High‐Power and Combined Very High‐Power Applications	10
Left Ventricular and Biventricular Multipoint Pacing With Dynamic Atrioventricular Delays: 6‐Month Cardiac Resynchronization Therapy Response	10
Exploring Optimal Cardiac Electronic Implantable Devices Programming: Reducing Non‐Actionable Alerts and Assessing Clinical Outcomes	10
An Interesting Response During Left Bundle Branch Area Pacing: Electrophysiological Insights	10
	10
Age and Clinically Actionable Events in Patients With Implantable Loop Recorders: Analysis of Multicenter Loop Recorder Registry	10
Early Recurrence of Atrial Tachyarrhythmias After Pulsed Field Ablation: New Technologies, Same (Blanking) Problems	10
Mind the gap: Recurrence of ventricular pre‐excitation after accessory pathway effective refractory period with short coupled paced stimuli	10
Limitation of Unipolar Electrograms in Guiding Successful RFCA of Idiopathic Ventricular Arrhythmias Associated With Discrete Pre‐Potential	10
Left Atrial Wall Thickness Measured by a Machine Learning Method Predicts AF Recurrence After Pulmonary Vein Isolation	10
Propensity‐Matched Five‐Year Cardiac Resynchronization Therapy Outcomes in Sarcoidosis With Heart Failure	10
Leadless versus transvenous single‐chamber ventricular pacemakers: 3 year follow‐up of the Micra CED study	10
Impact of Sodium‐Glucose Co‐Transporter 2 Inhibitors on Atrial Fibrillation Recurrence Post‐Catheter Ablation Among Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis	10
Surpoint algorithm for improved guidance of ablation for ventricular tachycardia (SURFIRE‐VT): A pilot study	10
Endocardial Atrial Lesion Characteristics With Pentaspline Pulsed Field Ablation: Insights From Serial Mapping in Patients	9
Conduction System Pacing With Stylet Driven Leads: A Step‐By‐Step Guide to Implant	9

Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long‐term outcomes in patients with and without structural heart disease	9
Feasibility and Clinical Efficacy of Focal Pulsed Field Ablation in Patients With Non‐Pulmonary Vein Triggered Atrial Arrhythmia From the Superior Caval Vein	9
Initial Clinical Experience With a Novel 4D Intracardiac Echocardiographic Imaging and Guidance System in Catheter Ablation Procedures	9
The coronary sinus Marshall structure: From an anatomical ligament to an arrhythmogenic vein	9
Six‐Month Emergent Readmissions Following Hospitalization for Atrial Fibrillation Amid the Syrian Conflict: A Real‐World Observational Cohort Study	9
Efficacy and durability of posterior wall isolation with ethanol infusion into the vein of Marshall	9
Association between temperature and air pollutants with atrial fibrillation presentations to emergency departments	9
Early and late Watchman device migration and embolization: Insights from the NCDR LAAO registry	9
Reply to “Challenges to the Claimed Safety and Feasibility of Atrial Fibrillation Ablation and Left Atrial Appendage Occlusion Without Onsite Cardiothoracic Surgery”	9
Precise Activation Within the Triangle of Koch: Insights from Ultra‐High‐Resolution Mapping and Cryoablation Terminating AVNRT	9
Author Response to: Expanding the Biophysical Insights Into Esophageal Heating During Radiofrequency Ablation	9
Tricuspid valve damage and improvement following transvenous lead extraction procedures	9
Predictors of low‐voltage zones in patients with persistent atrial fibrillation eligible for catheter ablation: An observational study	9
Machine learning identifies esophageal luminal temperature patterns associated with thermal injury in catheter ablation for atrial fibrillation	9
Metabolic effects of the left atrial appendage exclusion (the heart hormone study)	9
Cryoballoon for heart failure: Time to consider earlier	9
Early ablation of newly diagnosed paroxysmal atrial fibrillation (NEWPaAF) versus newly diagnosed persistent atrial fibrillation (NEWPeAF): Comparison of patient populations and ablation outcomes	9
Impact of intracardiac echocardiography usage on the safety of cryoballoon atrial fibrillation ablation: Subanalysis of the prospective FREEZE cluster cohort study	9
Characteristics of Left Ventricular Endocardial Electroanatomic Voltage Mapping in Patients With Tachycardia‐Induced Cardiomyopathy	9
Incidence and Characteristics of Superior Vena Cava Impact After Pulsed‐Field Ablation of the Right Pulmonary Veins	9
Outcomes of Transvenous Lead Removal in Patients With Prior Mediastinal Radiation	9
Pulsed‐Field Ablation: What We Know and What We Don't	9
Atrial Fibrillation Ablation During Hospitalization for Acute Heart Failure: Feasibility and Role of Pulsed Field Ablation	9
Incidental left atrial appendage isolation after catheter ablation of persistent atrial fibrillation: Mechanisms and long‐term risk of thromboembolism	9
The advantage of the mini‐electrode‐equipped catheter for the radiofrequency ablation of paroxysmal supraventricular tachycardia	9
Quantitative assessment of transient autonomic modulation after single‐shot pulmonary vein isolation with pulsed‐field ablation	8
Acute Nonsustained Mitral Isthmus Block Obtained With Sphere‐9 Lattice‐Tip Catheter Completed With Vein of Marshall Ethanol Infusion	8
Left bundle branch area pacing using a lumenless lead for LBBAP: Safety and efficacy in a new use‐case	8
Association between high‐density mapping of atypical atrial flutter, clinical outcomes and healthcare utilization	8
Therapeutic Strategy for Patients With Heart Failure and Atrial Fibrillation	8
Low voltage area guided substrate modification in nonparoxysmal atrial fibrillation: A systematic review and meta‐analysis	8
Pulsed field ablation in patients with complex consecutive atrial tachycardia in conjunction with ultra‐high density mapping: Proof of concept	8
Raise‐up technique for the creation of left atrial roof lesion: A useful technique with cryoballoon for persistent atrial fibrillation	8
Pulsed Field Ablation Systems for Atrial Fibrillation	8
Pacing induced tricuspid regurgitation: Does the lead matter?	8
Issue Information	8
Difference in Cerebral Microembolization With Multielectrode Pentaspline or Variable‐Loop Circular PFA Systems	8
Issue Information	8
Watchman device migration and embolization: A report from the NCDR LAAO Registry	8
Efficacy of the peak frequency map for left atrial posterior wall isolation	8
Trends in Mortality Related to Atrial Fibrillation and Dementia in Older Adults in the United States: A 2000–2020 Analysis	8
Reconsidering the Antiarrhythmic Role of Sodium–Glucose Cotransporter‐2 Inhibitors After Atrial Fibrillation Ablation	8
TEE versus ICE for LAAO: Is ICE just as nice?	8
Successful ablation of a right concealed epicardial accessory pathway using ethanol infusion	8
Understanding Atrial Fibrillation Complexity Through the Lens of Turbulence Dynamics: Implications for Treatment Strategies	8
Isolated JUP plakoglobin gene mutation with left ventricular fibrosis in familial arrhythmogenic right ventricular cardiomyopathy	8
A novel single shot pulsed field ablation catheter: Where does it stand and where do we go from here?	8
Issue Information	8
Consistency of ablations with trainee and increasing independence during fellowship training—Analysis of ablation data by CARTONET	8
Atrial fibrillation detection using insertable cardiac monitor after stroke: A real‐world cohort study	8
Outcomes of vascular closure devices for femoral venous hemostasis following catheter ablation of atrial fibrillation	8
Left atrial epicardial adipose tissue exacerbates electrical conduction disturbance in normal‐weight patients undergoing pulmonary vein isolation for atrial fibrillation	8
Atrial fibrillation recurrences during the blanking period after catheter ablation with the laser balloon technique	8
Novel methodology for the evaluation of symptoms reported by patients with newly diagnosed atrial fibrillation: Application of natural language processing to electronic medical records data	8
Comparison of three different approaches to very high‐power short‐duration ablation using the QDOT‐MICRO catheter	8
Epicardial mapping and ablation of biatrial macroreentrant tachycardia via Bachmann's bundle	8
Same day discharge after transvenous lead extraction: Balancing safety and efficiency	8
RETRACTION: A Comparison of Procedure‐Related Adverse Events Between Two Right Ventricular Leadless Pacemakers	8
Effects of parameters on radiofrequency guidewire ablation: In vitro and in vivo experiments	7
Long‐Term Follow‐Up After Atrioventricular Node Ablation in Patients With Atrial Fibrillation: A Nationwide Danish Cohort Study	7
Significance of the local largest bipolar voltage for the optimized ablation strategy using very high‐power short duration mode	7
Entrainment response during ventricular tachycardia originating from the para‐Hisian region: What is the mechanism?	7
Ex‐vivo histopathologic examination of irrigated radiofrequency ablation utilizing half‐normal saline of the human heart	7
Inferior lead QRS discordance on surface electrocardiogram predicting right anterior accessory pathways: A simplified approach	7
Artificial Intelligence‐Enabled Short‐Term Ambulatory Monitoring ECG During Sinus Rhythm for Prediction of Hidden Atrial Fibrillation	7
Reply to Letter to Editor: How to Prevent Silent Cerebral Embolism During Left Ventricular Ablation	7
Preclinical evaluation of semi‐automated laser ablation for pulmonary vein isolation: A comparative study	7
Fluoroless Mapping and Ablation With Integration of a Pentaspline Pulsed Field Catheter	7
	7
Association between residual unipolar voltage and arrhythmia recurrence after left atrial posterior wall isolation for persistent atrial fibrillation	7
Challenges in cardiac implantable electronic device surveillance: Insights from real‐world data	7
Peak frequency mapping of atypical atrial flutter	7
Left bundle branch area pacing using a lumenless lead: A systematic literature review and meta‐analysis	7
Differences Between the Unipolar Versus Bipolar Potential‐Based Activation Maps of Ventricular Premature Contractions Arising From Ventricular Outflow Tracts	7
Conduction time around the mitral valve annulus has the potential to rule out postablation perimitral atrial tachycardia	7
Radiofrequency energy floats, and heat sinks: The effects of convective cooling on lesion formation	7
Issue Information	7
Vein of Marshall Ethanol Ablation as a Strategy for Recurrent Persistent Atrial Fibrillation	7
Acute Atrial Pacing Threshold Elevation in an Auricular Leadless Pacemaker During Monopolar Pulsed Field Ablation of the Right Inferior Pulmonary Vein: A First‐in‐Human Case	7
When Close Is Not Close Enough: Cardiomyopathy After Deep Septal Pacing	7
Ablating Misconceptions to Prevent Failure of Interpretation: Revisiting the CLAPHAF Study	7
Three‐Dimensional Mapping of the Left Atrial Wall Rather Than the Left Atrial Chamber	7
Changing the view: Preventing pneumothorax during transvenous pacemaker implantation	7
Initial experience with stylet‐driven versus lumenless lead delivery systems for left bundle branch area pacing	7
Impact of Emergent Physician Notifications from Mobile Cardiac Outpatient Telemetry on Patient Outcomes (The EP‐COT Trial)	7
Thirty‐day mortality risk in patients following radiofrequency and cryoballoon ablation for atrial fibrillation across the entire nation of Poland: An 8‐year analysis from the National Health Fund of	7
Characteristics and outcome of wearable cardioverter‐defibrillator therapy stratified by gender: Insights from a multicenter international registry	7
Ventricular arrhythmias related to COVID‐19 infection and vaccination in patients with Brugada syndrome: The importance of a correct patient stratification	7
Short Sleep Duration Measured by Smartwatch Is Associated With Elevated Resting Heart Rate and Reduced Nocturnal Oxygen Saturation: Insights From Heartbeat	7
Leadless cardiac ventricular pacing using helix fixation: Step‐by‐step guide to implantation	7
Issue Information	7
Long‐Term Outcomes of Cryoballoon Pulmonary Vein Isolation Freeze Using a Modified ICE‐T Protocol With a Double 120 s Applications (ICE‐T 2 × 2)	7
Development of a clinically relevant ex vivo model of cardiac ablation for testing of ablation catheters	7
Distribution of excitation recoverable myocardium after radiofrequency ablation and its relation to energy application time and irrigation	7
Abandoning Non Invasive Risk Stratification in WPW: There Is no Such Thing as a Free Lunch	6